SYNERGIA MEDICAL ANNOUNCES STRONG RESULTS FOR NAO.VNS™ FIRST-IN-HUMAN STUDY Primary safety endpoint met - No serious adverse events reported over 3-monthsRobust device performance - No device failure reported over 3-months Synergia Medical announces that its NAO.VNS™...

SYNERGIA MEDICAL ANNOUNCES: FIVE PATIENTS NOW IMPLANTED WITH NAO.VNS™ LEADERSHIP CHANGE: CHARLES NOLET TO SUCCEED ATTILA BORBATH AS CEO Brussels, January 13, 2025. Synergia Medical SA, a leader in developing optoelectronic medical devices, is pleased to announce the successful implantation of its groundbreaking NAO.VNSTM system in...

Synergia Medical Successfully Implants First Patients With NAO.VNS™ Brussels, 23 September 2024 – Synergia Medical, a leader in the development of optoelectronic medical devices, is pleased to announce the successful implantation of its groundbreaking NAO.VNS system...